⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL36005 | 1.00 | — | — | |
| Bromide SCHEMBL16498145 | 0.98 | ALDH1A1 (0.43) | — | |
| Hydrochloric Acid SCHEMBL7113757 | 0.98 | ALDH1A1 (0.43) | — | |
| Butadiene SCHEMBL11085054 | 0.96 | ALDH1A1 (0.42) | — | |
| SCHEMBL9343099 | 0.92 | ALDH1A1 (0.44) | — | |
| Styrene SCHEMBL10707688 | 0.90 | ALDH1A1 (0.54) | — | |
| SCHEMBL11456228 | 0.88 | ALDH1A1 (0.41) | — | |
| Phosphoric Acid SCHEMBL16498035 | 0.88 | HDAC1 (0.41) | — | |
| SCHEMBL11017339 | 0.88 | ALDH1A1 (0.37) | — | |
| Sulfuric Acid SCHEMBL6439967 | 0.88 | TDP1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4203922-A1 | MCL-1 INHIBITOR FORMULATIONS | Amgen Inc. (US) | 2023-07-05 | — | — | EP | claimed |
| WO-2022046690-A1 | MCL-1 INHIBITOR FORMULATIONS | AMGEN INC. (US) | 2022-03-03 | — | — | WO | claimed |
| US-12612366-B2 | Salts and crystal forms of omecamtiv mecarbil | AMGEN INC. (US) | 2026-04-28 | — | — | US | disclosed |
| WO-2025111424-A1 | PARTICULATE VINYLAMINE COMPOSITIONS AND METHOD OF MAKING | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | disclosed |
| WO-2025111425-A1 | A METHOD OF PRODUCING VINYLAMINE-CONTAINING POLYMERS | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | disclosed |
| WO-2025111428-A1 | METHOD FOR PRODUCTION OF VINYL CARBOXAMIDE CONTAINING POLYMERS IN PARTICULATE FORM | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | disclosed |
| CN-120051593-A | Compositions and methods for nano twinned copper formation | 麦克德米德乐思公司 | 2025-05-27 | — | — | CN | disclosed |
| WO-2025074279-A1 | ANTI-SCRATCH COMPOSITIONS AND ARTICLES COMPRISING THE SAME | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-04-10 | — | — | WO | disclosed |
| WO-2025074278-A1 | ANTI-SCRATCH COMPOSITIONS AND ARTICLES COMPRISING THE SAME | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-04-10 | — | — | WO | disclosed |
| WO-2025032111-A1 | METHOD FOR RECOVERING METHYL AND VINYL SUBSTITUTED PYRIDINES | ARXADA AG (CH) | 2025-02-13 | — | — | WO | disclosed |
| EP-4413064-A1 | DECONTAMINATION BATH AND METHOD FOR DECONTAMINATING A PLASTIC ARTICLE | Smart Coloring GmbH (DE) | 2024-08-14 | — | — | EP | disclosed |
| EP-4004093-A1 | METHOD FOR REVERSIBLE AND SELECTIVE DYEING OF A SYNTHETIC POLAR-POLYMER MATERIAL; DYED SYNTHETIC POLAR-POLYMER MATERIAL AND ARTICLE THEREOF | Smart Coloring GmbH (DE) | 2022-06-01 | — | — | EP | disclosed |
| EP-3999609-A1 | USE OF POLYMERIC-INORGANIC NANOPARTICLE COMPOSITIONS AS HEAT TRANSFER FLUIDS IN BATTERY OR OTHER ELECTRICAL EQUIPMENT SYSTEMS | Evonik Operations GmbH (DE) | 2022-05-25 | — | — | EP | disclosed |
| EP-3999610-A1 | USE OF NANOPARTICLE COMPOSITIONS AS HEAT TRANSFER FLUIDS IN BATTERY OR OTHER ELECTRICAL EQUIPMENT SYSTEMS | Evonik Operations GmbH (DE) | 2022-05-25 | — | — | EP | disclosed |
| EP-3990595-A1 | COMPOSITIONS COMPRISING A GRAPHENE-BASED MATERIAL AS LUBRICANT ADDITIVES | Evonik Operations GmbH (DE) | 2022-05-04 | — | — | EP | disclosed |
| WO-2022058095-A1 | COMPOSITIONS COMPRISING A GRAPHENE-BASED MATERIAL AS LUBRICANT ADDITIVES | EVONIK OPERATIONS GMBH (DE) | 2022-03-24 | — | — | WO | disclosed |
| WO-2022049149-A1 | CHEWABLE FORMULATIONS | ELANCO TIERGESUNDHEIT AG (CH) | 2022-03-10 | — | — | WO | disclosed |
| WO-2022051478-A1 | PALATABLE FORMULATIONS | ELANCO US INC. (US) | 2022-03-10 | — | — | WO | disclosed |
| WO-2022046690-A1 | MCL-1 INHIBITOR FORMULATIONS | AMGEN INC. (US) | 2022-03-03 | — | — | WO | disclosed |
| CN-114126597-A | Fibroblast activation protein inhibitor | 普拉西斯生物技术有限责任公司 | 2022-03-01 | — | — | CN | disclosed |